Investor insights
Sectors invested in
Funding rounds participated in
$1.5M sweet spot round size
Most of their 12 investments are in rounds between $30M and $80M
Investor type
Basic info
Industry
Sectors
Date founded
2017
Investments made
OnKure Therapeutics raised $54M on May 23, 2023
Investors: Surveyor Capital, Samsara BioCapital, Perceptive Advisors and Acorn Bioventures
CG Oncology raised $120M on November 15, 2022
Investors: RA Capital Management, L.P., ORI Capital Limited, Sirona Capital, Longitude Capital, Decheng Capital and Acorn Bioventures
X4 Pharmaceuticals raised $55M on June 30, 2022
Investors: Hercules Capital, Inc., AXA Investment Managers, Lumira Ventures, OrbiMed Advisors and Acorn Bioventures
Neuron23 Inc. raised $100M on March 30, 2022
Investors: HBM Partners AG, SoftBank Investment Advisers, Westlake Village BioPartners®, Perceptive Advisors, Surveyor Capital, Kleiner Perkins, Redmile Group and Acorn Bioventures
ONK Therapeutics raised $22M on January 6, 2022
Investors: Acorn Bioventures
Undisclosed raised $30M on September 3, 2021
Investors: Innogest Capital, Ikarian Capital LLC, Longview Ventures, RTW Investments, LP, Altium Capital, Sio Capital Management LLC, Surveyor Capital, Affinity Asset Advisors and Acorn Bioventures
OnKure Therapeutics raised $57M on March 4, 2021
Investors: Surveyor Capital, Perceptive Advisors, Samsara BioCapital and Acorn Bioventures
Aileron Therapeutics raised $36M on January 6, 2021
Investors: Lincoln Park Capital, LLC and Acorn Bioventures
Neuron23 Inc. raised $80M on December 16, 2020
Investors: Kleiner Perkins, Surveyor Capital, Perceptive Advisors, Westlake Village BioPartners®, HBM Partners AG, Redmile Group and Acorn Bioventures
Q32 Bio Inc. raised $60M on October 29, 2020
Investors: Sanofi Ventures, OrbiMed Advisors, University of Colorado, Abingworth, Atlas Venture, Osage University Partners (OUP) and Acorn Bioventures